|
|
|
August 27, 2012
|  Editor: Ahmed Enany
President & CEO
Southern California
Biomedical Council
enany@socalbio.org
www.socalbio.org
|
| RSVP Now | |
Featuring presentation on
Bioscience Regions in the U.S. Trends, Best Practices and Competitive Strategies
by
Mitch Horowitz, Managing Director
Battelle Technology Partnership
| |
|
| Leadership |
ImmunoCellular Therapeutics Appoints John S. Yu, MD, as Interim Chief Executive Officer
 The company announced in a press release last week that the Board of Directors appointed John S. Yu, MD, as Interim Chief Executive Officer and President, and accepted the resignation of Manish Singh, PhD, effective immediately, from the CEO, President, and Board positions. Dr. Yu will continue to serve as Chief Scientific Officer and Chairman of the Board. ImmunoCellular has initiated a search for a permanent chief executive officer .... Read more
Related
|
| Chapter 11 |
The Northridge, CA-Based Gamma Media-Idea
Files for Chapter 11
 On August 20, 2012, Gamma Medica-Ideas (USA), Inc. filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the Central District of California. Gamma Medica-Ideas, Inc. designs, builds, and services molecular breast digital imaging systems, radiation detector systems, application specific integrated circuits, and medical devices for researchers in academia, pharmaceutical companies, and contract research organizations worldwide ... Read more
|
| Keynote |
Alcon's Peter Richardson Will Keynote the Upcoming SoCalBio Investor Conference
 SoCalBio is pleased to announce that Mr Richardson, who heads Alcon's clinical and regulatory affairs, will serve as a keynote speaker during the 14th Annual SocalBio Investor and Partnership Conference to be held on November 7 at the Omni Hotel in downtown Los Angeles. Mr. Richardson will talk about partnering for innovation and provide an overview of Alcon's expanding presrence in Southern California. Mr. Richardson previously served as Chief Scientific Office for MannKind Corporation in Valencia and Sr. Vice President at Novartis. The SoCalBio Investor Conference is a showcase for emerging biotech and device companies. It will feature, among other things, over 40 presentations by bioscience companies seeking funding or partners ... RSVP to attend
|
| Register Now |
Southern California Biggest Celebration of
Emerging Bioscience Companies
Company Presentations . Keynote Speeches . Panel Discussions . Exhibits . Poster Show . Networking Opportunities
November 7, 2012 -- Omni Hotel in Downtown Los Angeles
Sponsorship and Exhibit Opportunities Available
Interested in making a business presentation during this conference? Please send an executive summary to scbc@socalbio.org
|
| Med Device R&D |
Who Spends the Most of Medical Device R&D?
 Alcon, Johnson & Johnson, Siemens, GE and Toshiba top the list of med device R&D big spenders according to MassDevice.com's Big 100 database of the 100 largest med-tech makers .. Read more
|
| Reserve Your Spot | |
We Are Determined to Make Your
Participation Memorable
Hit a Hole in One, Win a Toyota Prius C
For details, call SoCalBio at 800-418-7079 or send email at scbc@socalbio.org
|
| Partnerships |
Allergan and Molecular Partners Enter
into Exclusive Alliance
 The Irvine-based Allergan, Inc.and the Swiss Molecular Partners AG announced that they have significantly expanded their existing relationship by entering into two separate agreements to discover, develop, and commercialize proprietary therapeutic DARPin products for the treatment of serious ophthalmic diseases ... Read more
|
| Ophthalmology |
Global Opthalmology Drug and Device Market
to Reach $52.4B by 2017
 A MarketsandMarkets report predicts that the global market for ophthalmology devices and drugs will reach $52.4 billion in 2017, driven by evolving demographics, an aging population and a growing emphasis on combination drug therapies. The report also notes that the Asia Pacific region will achieve the fastest growth, particularly in China and India ... Read more
|
| Diagnostics |
Health Care Reform Means Greater Reliance on Diagnostic Tools and Equipment
This Is Good News for Southern California Burgeoning Dx and Device Clusters
 The Wall Street Transcript has just published its Medical Research, Diagnostic Substances and Life Science Tools Report offering a timely review of the sector to serious investors and industry executives ... Read more
|
| Expansion |
 STAAR Surgical Expands Footprint in Monrovia
The ophthalmic device maker STAAR Surgical signed a lease on a 26,000 square foot building immediately adjacent to its current facility in Monrovia, California. The new building will allow the Company to accommodate the needs associated with its previously announced manufacturing consolidation to Monrovia, as well as provide space for additional growth... Read more |
| SoCalBio Membership Saves You Money | |
Become a SoCalBio Member and save money through utlizing the SoCalBio Group Purchasing Program
Video Recap of SoCalBio Open House
|
| Emerging Markets |
China Set to Increase Number of Drugs
Subject to Price Controls
 China's official Shanghai Securities Journal reports that the government will increase the number of drugs on its "essential drugs" list to 700 from 307 by the end of the year. Drugs on the list are deemed critical to the health of the population, procured by the government, and subject to price controls ... Read more
|
| Biotech Jobs |
 Top Ten Biotech Jobs Most in Demand Over The Next Decade
Click here to see the list of Jobs in demand based on statistics from the U.S. Bureau of Labor Statistics |
| Jobs Available |
A Southern California stem cell company focused on wound healing is seeking to fill the following position:
- COO/CFO (The CFO/COO must possess a unique blend of strategic, financial and operational savvy, a big-picture vision, and the drive to make that vision a reality. The role will require travel to satellite offices/subsidiaries in Europe, the Middle East, Australia and Asia to review/audit financial programs and practices. Send resume to brandon@socalbio.org)
Response Genetics (Los Angeles)
Holomic (Los Angeles)
|
|
| About SoCalBio |
 SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|
